Fluid Processing Systems Including An Electroporation Device

US2025058029A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2025058029-A1
Application numberUS-202418937842-A
CountryUS
Kind codeA1
Filing dateNov 5, 2024
Priority dateMar 5, 2019
Publication dateFeb 20, 2025
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A fluid processing system includes a separation device, a mononuclear cell product processing device, a pump assembly, and a controller. The controller is programmed to actuate the pump assembly to convey blood from a blood source into the separation device, actuate the separation device to separate a mononuclear cell product from the blood, and actuate the pump assembly to convey at least a portion of the mononuclear cell product through the mononuclear cell product processing device to modify a genome of at least one of the cells of the mononuclear cell product and create a modified mononuclear cell product. The controller is programmed to selectively actuate the pump system to convey the mononuclear cell product through the mononuclear cell product processing device in either a first direction or in an opposite, second direction to modify the genome of at least one of the cells of the mononuclear cell product.

First claim

Opening claim text (preview).

1 - 20 . (canceled) 21 . A fluid processing system, comprising: a separation device; a mononuclear cell product processing device; a pump assembly including a plurality of pumps; and a controller programmed to actuate the pump assembly to convey blood from a blood source into the separation device, actuate the separation device to separate a mononuclear cell product from the blood, and actuate the pump assembly to convey at least a portion of the mononuclear cell product through the mononuclear cell product processing device to modify a genome of at least one of the cells of the mononuclear cell product and create a modified mononuclear cell product, wherein the controller is programmed to selectively actuate the pump system to convey said at least a portion of the mononuclear cell product through the mononuclear cell product processing device in a first direction to modify the genome of said at least one of the cells of the mononuclear cell product and actuate the pump system to convey said at least a portion of the mononuclear cell product through the mononuclear cell product processing device in a second direction that is opposite to the first direction to modify the genome of said at least one of the cells of the mononuclear cell product. 22 . The fluid processing system of claim 21 , wherein the separation device comprises a centrifuge. 23 . The fluid processing system of claim 21 , wherein the controller is programmed to actuate the pump system to convey said at least a portion of the mononuclear cell product through the mononuclear cell product processing device in said first direction without first washing said at least a portion of the mononuclear cell product. 24 . The fluid processing system of claim 21 , wherein the controller is programmed to actuate the pump system to convey said at least a portion of the mononuclear cell product through the mononuclear cell product processing device in said second direction after said at least a portion of the mononuclear cell product has been washed. 25 . The fluid processing system of claim 21 , further comprising a second separation device configured to be actuated by the controller to wash the mononuclear cell product and/or the modified mononuclear cell product. 26 . The fluid processing system of claim 25 , wherein the controller is programmed to actuate the second separation device to wash said at least a portion of the mononuclear cell product prior to actuating the pump assembly to convey said at least a portion of the mononuclear cell product through the mononuclear cell product processing device. 27 . The fluid processing system of claim 25 , wherein the controller is programmed to actuate the second separation device to wash the modified mononuclear cell product after actuating the pump assembly to convey said at least a portion of the mononuclear cell product through the mononuclear cell product processing device. 28 . The fluid processing system of claim 25 , wherein the controller is programmed to actuate the second separation device to wash said at least a portion of the mononuclear cell product prior to actuating the pump assembly to convey said at least a portion of the mononuclear cell product through the mononuclear cell product processing device and to actuate the second separation device to wash the modified mononuclear cell product after actuating the pump assembly to convey said at least a portion of the mononuclear cell product through the mononuclear cell product processing device. 29 . The fluid processing system of claim 25 , further comprising an outlet sensor associated with the second separation device and configured to detect optical characteristics of a waste product exiting the second separation device. 30 . The fluid processing system of claim 21 , wherein the controller is programmed to actuate the pump assembly to collect and retain at least a portion of the modified mononuclear cell product for a holding time prior to conveying said least a portion of the modified mononuclear cell product to the blood source. 31 . The fluid processing system of claim 21 , wherein the controller is programmed to actuate the pump assembly to convey at least a portion of the modified mononuclear cell product to the blood source without first collecting and retaining said at least a portion of the modified cell product for a holding time. 32 . The fluid processing system of claim 21 , wherein the mononuclear cell product processing device is not configured to add DNA material to said at least a portion of the mononuclear cell product. 33 . The fluid processing system of claim 21 , wherein the controller is programmed to actuate the pump assembly to convey said at least a portion of the mononuclear cell product through the mononuclear cell product processing device after DNA material has been added to the mononuclear cell product. 34 . The fluid processing system of claim 21 , wherein the controller is programmed to actuate the pump assembly to add DNA material to the mononuclear cell product. 35 . The fluid processing system of claim 34 , wherein the controller is programmed to actuate the pump assembly to retain the mixture of the DNA material and the mononuclear cell product for a holding time prior to actuating the pump assembly to convey said at least a portion of the mononuclear cell product through the mononuclear cell product processing device. 36 . The fluid processing system of claim 21 , wherein the mononuclear cell product processing device comprises an electroporation device.

Assignees

Inventors

Classifications

  • with blood pumping means or components thereof · CPC title

  • at least one cassette surface or portion thereof being flexible, e.g. the cassette having a rigid base portion with preformed channels and being covered with a foil · CPC title

  • Details of valves · CPC title

  • with sensing means or components thereof · CPC title

  • the interface providing means for actuating on functional elements of the cassette, e.g. plungers · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2025058029A1 cover?
A fluid processing system includes a separation device, a mononuclear cell product processing device, a pump assembly, and a controller. The controller is programmed to actuate the pump assembly to convey blood from a blood source into the separation device, actuate the separation device to separate a mononuclear cell product from the blood, and actuate the pump assembly to convey at least a po…
Who is the assignee on this patent?
Fenwal Inc
What technology area does this patent fall under?
Primary CPC classification A61M1/3696. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Thu Feb 20 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).